Sherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy

Dr. Sherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1995 in Hypertension
Verified
Journal Article
Closed access
MIM. Mohsen Ibrahim
M. Mohsen Ibrahim
HRHussein Rizk
Hussein Rizk
LALawrence J. Appel
Lawrence J. Appel
WAWafaa El Aroussy
Wafaa El Aroussy
SHSherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy
Sherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy
PWPaul K. Whelton
Paul K. Whelton
This report from the Egyptian National Hypertension Project presents national estimates of the prevalence of hypertension and the extent to which high blood pressure is being detected, treated with medications, and controlled in the Egyptian population. The results are based on findings from a national probability survey of adults ≥25 years of age conducted in six Egyptian governorates. With the use of a stratified multistage probability design, 6733 people (85% response rate) were examined. Hypertension was defined as systolic pressure ≥140 mm Hg, and/or diastolic pressure ≥90 mm Hg, and/or reported treatment with one or more antihypertensive medications. Overall, the estimated prevalence of hypertension in Egypt was 26.3%. Hypertension prevalence increased progressively with age, from 7.8% in 25- to 34-year-olds to 56.6% in those 75 years or older. Hypertension was slightly more common in women than in men (26.9% versus 25.7%, respectively). Overall, 37.5% of hypertensive individuals were aware that they had high blood pressure, 23.9% were being treated with antihypertensive medications, and 8.0% were under control (systolic pressure <140 mm Hg and diastolic pressure <90 mm Hg). Hypertension prevalence as well as awareness, treatment, and control rates varied by region, with Cairo having the highest prevalence (31.0%) and the Coastal Region having the highest control rate (15.9%). Rates of awareness, treatment, and control tended to be lowest in areas of lower socioeconomic status. Our results indicate that hypertension is highly prevalent in Egypt and that the rates of hypertension awareness, treatment, and control are relatively low. These findings argue for a nationwide effort to prevent and control high blood pressure in Egypt in order to avert an epidemic of cardiovascular disease.

1 July 1992 in Heart
Verified
Journal Article
Open access
PDF file
BSB B Stojnic
B B Stojnic
SBS J D Brecker
S J D Brecker
HXH B Xiao
H B Xiao
SHSherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy
Sherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy
MMM Mbaissouroum
M Mbaissouroum
DGD G Gibson
D G Gibson
Objective—To examine the effects of pulmonary hypertension on left ventricular diastolic function and to relate the findings to possible mechanisms of interdependence between the right and left sides of the heart in ventricular disease. Design—A retrospective and prospective analysis of echocardiographic and Doppler studies. Setting—A tertiary referral centre for both cardiac and pulmonary disease. Patients—29 patients with pulmonary hypertension (12 primary pulmonary hypertension, 10 pulmonary fibrosis, five atrial septal defect (ASD), and two scleroderma) were compared with a control group of 10 patients with an enlarged right ventricle but normal pulmonary artery pressure (six ASD, one after ASD closure, one ASD and pulmonary valvotomy, one tricuspid valve endocarditis and repair, and one pulmonary fibrosis). None had clinical or echocardiographic evidence of intrinsic left ventricular disease. Main Outcome measures—M mode echocardiographic measurements were made of septal thickness, and left and right ventricular internal cavity dimensions. Doppler derived right ventricular to right atrial pressure drop, and time intervals were measured, as were isovolumic relaxation time, and Doppler left ventricular filling characteristics. Results—The peak right ventricular to right atrial pressure gradient was (mean (SD)) 60 (16) mm Hg in pulmonary hypertensive patients, and 18 (5) mm Hg in controls. The time intervals P2 to the end of the tricuspid regurgitation, and P2 to the start of tricuspid flow were both prolonged in patients with pulmonary hypertension compared with controls (115 (60) and 120 (40) ν 40 (15) and 45 (10) ms, p values <0·001). Pulmonary hypertensive patients commonly had a dominant A wave on the transmitral Doppler (23/29); however, all the controls had a dominant E wave. Isovolumic relaxation time of the left ventricle was prolonged in pulmonary hypertensive patients compared with controls, measured as both A2 to mitral valve opening (80 (25) ν 50 (15) ms) and as A2 to the start of mitral flow (105 (30) ν 60 (15) ms, p values <0·001). The delay from mitral valve opening to the start of transmitral flow was longer in patients with pulmonary hypertension (30 (15) ms) compared with controls (10 (10) ms, p < 0·001). At the time of mitral opening there was a right ventricular to right atrial gradient of 12 (10) mm Hg in pulmonary hypertensive patients, but this was negligible in controls (0·4 (0·3) mm Hg, p < 0·001). Conclusions—Prolonged decline of right ventricular tension, the direct result of severe pulmonary hypertension, may appear as prolonged tricuspid regurgitation. It persists until after mitral valve opening on the left side of the heart, where events during isovolumic relaxation are disorganised, and subsequent filling is impaired. These effects are likely to be mediated through the interventricular septum, and this right-left ventricular asynchrony may represent a hitherto unrecognised mode of ventricular interaction.

1 April 1990 in JACC
Verified
Journal Article
Closed access
KSKhalid H. Sheikh
Khalid H. Sheikh
JBJames R. Bengtson
James R. Bengtson
SHSherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy
Sherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy
CJCecilia Juarez
Cecilia Juarez
RBRobert Burgess
Robert Burgess
JKJoseph Kisslo
Joseph Kisslo

1 November 2001 in Journal Of Hypertension
Verified
Journal Article
Closed access
MIM. Mohsen Ibrahim
M. Mohsen Ibrahim
LALawrence J. Appel
Lawrence J. Appel
HRHussein H. Rizk
Hussein H. Rizk
SHSherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy
Sherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy
JMJonathan Mosley
Jonathan Mosley
PWPaul Whelton
Paul Whelton
To define the prevalence of cardiovascular risk factors and their relation to the level of blood pressure, in Egyptians. Data were collected during the Egyptian National Hypertension project, a national hypertension survey in Egypt. During phase I of the survey, hypertensive (HT) patients were identified. In phase II, clinical and laboratory evaluations were made on HT and gender-matched normotensives (NT). A total of 2313 individuals were examined, 311 NT males, 443 NT females, 670 HT males and 889 HT females. The prevalence of obesity was 33 and 47% in hypertensive men and women, respectively. After adjusting for age, HT men had significantly higher heart rate, total cholesterol (TC), triglycerides (TG), fasting blood sugar (FBS), post-prandial blood sugar (PBS), body mass index and waist/hip (W/H) ratio than their NT counterparts. In addition, HT women had higher low-density lipoprotein cholesterol (LDL-C). The prevalence of elevated LDL-C and FBS increased with age. The prevalence of hypertriglyceridemia, elevated FBS and obesity rose with increasing level of blood pressure (BP). From the 25–34 to the 55–64 age group, the percentage of hypertensives with ≥ 2 risk factors rose from 42.9 to 60.6% in men, and from 9.4 to 46.2% in women. All risk factors were more prevalent in urban populations. This is one of the few reports on the prevalence of cardiovascular risk factors in a developing country. Risk factors cluster with rising level of BP and with ageing. Obesity is very prevalent, particularly in hypertensive Egyptian women. Health efforts directed at the prevention and treatment of obesity should be a high priority.

1 January 2011 in Heart Views
Verified
Journal Article
Open access
PDF file
SHSherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy
Sherif Mahmoud Helmy Abdelaziz Mahmoud Helmy Abdelaziz Helmy
GMGomaa F Maauof
Gomaa F Maauof
ASAhmedA Shaaban
AhmedA Shaaban
AEAhmed M ElMaghraby
Ahmed M ElMaghraby
SASmitha Anilkumar
Smitha Anilkumar
RHRachel Hajar
Rachel Hajar
Background: Hypertrophic cardiomyopathy (HCM) is a genetic disease associated with risk of morbidity and sudden cardiac death. The prevalence, hypertrophy patterns, mode of presentations, and different ECG findings vary in different regions of the world. To date, no data is present regarding these variables in Qatar. Patients and Methods: A retrospective, cross sectional, descriptive analysis of all patients referred for echocardiography study at Hamad General Hospital, Qatar. The study period was from January 2008 till December 2010. Aims: To study 1) the prevalence of HCM, 2) the different patterns of hypertrophy, and 3) the clinical and ECG presentations in this population. Results: Out of the 29,286 cases evaluated, 38 patients were found to have HCM (0.13%). Their clinical, ECG, and echocardiography findings were analyzed. Mean age was 47 y, 35 males (92%) and 3 females (8%). Four patterns of hypertrophy were described; 17 (44.7%) had septal hypertrophy alone, 6 (15.8%) had septal and other segments hypertrophy but sparing the apex, 10 (26.3%) had apical segments along with any other segment hypertrophy, and 5 (13.2%) had apical hypertrophy alone. No obstruction was found in 19 (50%), left ventricular outflow (LVO) tract obstruction was found in 13 (34%), and mid cavity obstruction (MCO) in 6 (16%). Twenty one (55.3%) patients were referred because of chest pain, 15 (39.5%) with palpitations, 15 (39.5%) with shortness of breath, and 5 (13.2%) with syncope. Nine patients (23.7%) were asymptomatic and were referred because of cardiac murmur during routine examination. ECG evidence of LV hypertrophy was found in 29 (76.3%). Conclusion: The prevalence of HCM in our population group is 0.13% with a male predominance (12:1). There was a diversity of clinical presentation, ECG abnormalities and patterns of LV hypertrophy among HCM patients.

Verified
Journal Article
Open access
PDF file
ATAnas Tahir
Anas Tahir
OMOnur Mutlu
Onur Mutlu
Faycal BensaaliFaycal Bensaali
Faycal Bensaali
RWRabab Kreidieh Ward
Rabab Kreidieh Ward
AGAbdel Naser Ghareeb
Abdel Naser Ghareeb
Huseyin Cagatay YalcinHuseyin Cagatay Yalcin
Huseyin Cagatay Yalcin
Aortic valve defects are among the most prevalent clinical conditions. A severely damaged or non-functioning aortic valve is commonly replaced with a bioprosthetic heart valve (BHV) via the transcatheter aortic valve replacement (TAVR) procedure. Accurate pre-operative planning is crucial for a successful TAVR outcome. Assessment of computational fluid dynamics (CFD), finite element analysis (FEA), and fluid–solid interaction (FSI) analysis offer a solution that has been increasingly utilized to evaluate BHV mechanics and dynamics. However, the high computational costs and the complex operation of computational modeling hinder its application. Recent advancements in the deep learning (DL) domain can offer a real-time surrogate that can render hemodynamic parameters in a few seconds, thus guiding clinicians to select the optimal treatment option. Herein, we provide a comprehensive review of classical computational modeling approaches, medical imaging, and DL approaches for planning and outcome assessment of TAVR. Particularly, we focus on DL approaches in previous studies, highlighting the utilized datasets, deployed DL models, and achieved results. We emphasize the critical challenges and recommend several future directions for innovative researchers to tackle. Finally, an end-to-end smart DL framework is outlined for real-time assessment and recommendation of the best BHV design for TAVR. Ultimately, deploying such a framework in future studies will support clinicians in minimizing risks during TAVR therapy planning and will help in improving patient care.